Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Parkinson's Disease

  Free Subscription


10.12.2018

1 J Neural Transm (Vienna)
1 Neurobiol Dis
2 Neurology
1 PLoS Comput Biol
1 PLoS One
1 Proc Natl Acad Sci U S A


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    J Neural Transm (Vienna)

  1. MOSTILE G, Giuliano L, Dibilio V, Luca A, et al
    Complexity of electrocortical activity as potential biomarker in untreated Parkinson's disease.
    J Neural Transm (Vienna). 2018 Dec 3. pii: 10.1007/s00702-018-1961.
    PubMed     Text format     Abstract available


    Neurobiol Dis

  2. MUS L, Siani F, Giuliano C, Ghezzi C, et al
    Development and biochemical characterization of a mouse model of Parkinson's disease bearing defective glucocerebrosidase activity.
    Neurobiol Dis. 2018 Dec 3. pii: S0969-9961(18)30756.
    PubMed     Text format     Abstract available


    Neurology

  3. JUTTUKONDA MR, Franco G, Englot DJ, Lin YC, et al
    White matter differences between essential tremor and Parkinson disease.
    Neurology. 2018 Nov 30. pii: WNL.0000000000006694.
    PubMed     Text format     Abstract available

  4. KIM R, Lee J, Kim HJ, Kim A, et al
    CSF beta-amyloid42 and risk of freezing of gait in early Parkinson disease.
    Neurology. 2018 Nov 30. pii: WNL.0000000000006692.
    PubMed     Text format     Abstract available


    PLoS Comput Biol

  5. GRADO LL, Johnson MD, Netoff TI
    Bayesian adaptive dual control of deep brain stimulation in a computational model of Parkinson's disease.
    PLoS Comput Biol. 2018;14:e1006606.
    PubMed     Text format     Abstract available


    PLoS One

  6. OKUBADEJO NU, Rizig M, Ojo OO, Jonvik H, et al
    Leucine rich repeat kinase 2 (LRRK2) GLY2019SER mutation is absent in a second cohort of Nigerian Africans with Parkinson disease.
    PLoS One. 2018;13:e0207984.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  7. YAN R, Zhang J, Park HJ, Park ES, et al
    Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLB.
    Proc Natl Acad Sci U S A. 2018 Dec 3. pii: 1813365115.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: